Search results
Data-Based Insights About Merck & Co Inc
Stocks Register· 2 days agoMerck & Co Inc (NYSE:MRK) price on Thursday, May 09, rose 0.08% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $129.66. A look ...
Stocks Close Mixed As Fed Official Says This On Rate Cuts; Taiwan Semi Soars On Sales Report
Investor's Business Daily· 5 hours agoThe major market indexes closed mixed Friday as investors awaited a key inflation report next week....
Merck First Quarter 2024 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 5 days agoMerck (NYSE:MRK) First Quarter 2024 Results Key Financial Results Revenue: US$15.8b (up 8.9% from 1Q...
Merck's endometrial cancer therapy fails trial
AOL· 2 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after surgery. The trial did not meet the main ...
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
InvestorPlace· 15 hours agoA commonly used strategy for investing is sector rotation. A good example is the flow of funds into...
C4 Therapeutics Inc (CCCC) Q1 2024 Earnings: Navigating Challenges with Strategic Collaborations
GuruFocus.com via Yahoo Finance· 7 hours agoExpenses: Decreased to $22.5 million in Q1 2024 from $29.0 million in Q1 2023, reflecting prioritization of internal discovery efforts. Strategic Collaborations: Initiated a new collaboration ...
Gossamer sells rights to drug it hopes can rival a new Merck therapy
BioPharma Dive via Yahoo Finance· 5 days agoOne analyst thinks the collaboration “bodes well” for Gossamer, which has had trouble convincing...
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Zacks via Yahoo Finance· 10 hours agoPfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 5 days agoPRESS RELEASE - 06/05/2024, 07:00 CEST Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region ...
A Struggling Pfizer Looks for Help From a Wall Streeter
Barrons.com· 1 hour agoAs the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a...
